Published in:
Volume 3 / Year 2014 / Issue 4

Amgen’s move into the biosimilars market

Page: 202-3

Abstract: Biotech giant Amgen now has a biosimilars programme that includes nine different molecules. A representative from Amgen has spoken to GaBI about the company’s venture into biosimilars. Topics included… Read More »

Go Back Print